Harvoni (Ledipasvir/Sofosbuvir) is one of the most successful drugs in the treatment of hepatitis C worldwide. Harvoni combines Ledipasvir and Sofosbuvir, offering a highly effective cure.
What is Harvoni?
Harvoni is a direct-acting antiviral (DAA) used to treat chronic hepatitis C infection (HCV). It has high cure rates and transformed patient care.
Indications
-
Treatment of chronic hepatitis C (HCV).
Administration
-
Harvoni tablets are taken orally once daily.
Common Side Effects
-
Headache.
-
Fatigue.
-
Nausea.
Availability in Egypt
Harvoni in Egypt is available through pharmacies and treatment programs. Its price has become more affordable compared to international markets.
Conclusion
Harvoni (Ledipasvir/Sofosbuvir) remains one of the most powerful solutions against hepatitis C and played a key role in Egypt’s elimination program.
Contact Macrocare today to learn more about your personalized treatment plan.
